Researchers developed a rapid, non-invasive, point-of-care platform for the direct detection of SARS-CoV-2 in exhaled breath.
atai Life Sciences Makes $50m Investment in Beckley Psytech – Psychedelic Alpha
According to atai, this investment “reinforces atai’s position as the biopharmaceutical company with the largest and most diverse portfolio of clinical-stage psychedelic candidates”. It might